EP3250591
MANNLEG MÓTEFNI GEGN GLÝKÓPRÓTÍNI EBÓLUVEIRU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.1.2016EP published:
12.11.2025EP application number:
16703030.3
EP translation filed:
6.2.2026Grant published:
11.3.2026EPO information:
European Patent Register
Max expiry date:
24.1.2036Expiry date:
24.1.2027Next due date:
31.1.2027
Title in English:
HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEINLanguage of the patent:
English
Timeline
Today
25.1.2016EP application
12.11.2025EP Publication
6.2.2026Translation submitted
11.3.2026Registration published
24.1.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
KYRATSOUS, ChristosAddress:
Tarrytown, New York 10591, US
Name:
OLSON, WilliamAddress:
Tarrytown, New York 10591, US
Name:
MASON, PeterAddress:
Somerville, MA 02144, US
Name:
STAHL, NeilAddress:
Tarrytown, New York 10591, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201562107581 PDate:
26.1.2015Country:
US
Number:
201562161356 PDate:
14.5.2015Country:
US
Number:
201562245703 PDate:
23.10.2015Country:
US
Classification
Categories:
C07K 16/10, A61K 39/395, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 28.1.2026
Expires: 24.1.2027
Payer: Árnason Faktor ehf.